drugset / Trial / NCT03123406

Efficacy and Safety of Cinacalcet in Ca, P and iPTH Levels in Patients With Mild, Moderate and Severe SHPT

NCT03123406

Phase 4 Completed 750 enrolled Kyowa Kirin Co., Ltd.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

1. To evaluate achievement ratio of iPTH,Calcium and phosphorus after taking Cinacalcet HCL in hemodialysis subjects with mild, moderate and severe SHPT; 2. To explore the impact of Cinacalcet HCL using on the combined use of drugs; 3. To explore the difference of patients who continued or discontinued Cinacalcet HCL in real-world period from 33rd to 52nd week.

Timeline

Start
2017-04-19
Primary completion
2019-04-20
Completion
2019-09-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Cinacalcet Other / unclassified